News

The agreement is Burnham’s first broad-based partnership with a large pharmaceutical company. Under this multi-year agreement, Burnham will provide Johnson & Johnson Pharmaceutical R&D (J&JPRD) with access to

The partnership between PRA Taiwan, the Taiwanese subsidiary of PRA International, Mediscience and LSK encompasses the joint management of multinational clinical trials in Asia as well as related

Schering-Plough will also collaborate with Symyx to develop within the Symyx Notebook a commercial metrology module built on the Symyx Lab Operational Informatics platform. The metrology module will

Viprinex was recently studied in a clinical trial to determine whether it was effective in improving patient outcome when given within six hours of a stroke, but the

Ms Miller has held senior positions in business development, including the title of vice president, in various companies including Anesiva, Theravance, Scios Pharmaceuticals, Onyx Pharmaceuticals and Procter &

Following clearance of the investigational new drug (IND) application by the FDA, Pluristem will initiate Phase I dose ranging clinical trials during the first half of 2009 at

The PER.C6 platform allows ProFibrix to manufacture recombinant human fibrinogen at levels that support the development and commercial rollout of new products. The company’s lead product Fibrocaps is

Novartis has announced that the US Department of Health and Human Services, Biomedical Advanced Research and Development Authority (HHS, BARDA) has awarded Novartis Vaccines a contract for up

She previously worked for Focus Diagnostics/Quest for over 20 years in a wide-ranging role encompassing sales and marketing, technical advisory and business development. Stephen Little, chief executive officer